Ag. Murray et al., Neonatal porcine islet cells induce human CD4(+), but not CD8(+), lymphocyte proliferation and resist cell-mediated cytolytic injury in vitro, DIABETES, 48(9), 1999, pp. 1713-1719
Xenotransplantation of porcine tissue to human recipients promises to allev
iate the organ shortage. Human antibody-mediated and cell-mediated immune r
esponses against porcine grafts, however, represent barriers to successful
xenotransplantation. We compared neonatal porcine islet cells (NPICs) and n
eonatal porcine splenocytes for the ability to stimulate proliferation of h
uman peripheral blood lymphocytes (PBLs), and for their susceptibility to h
uman natural killer (NK) and cytotoxic T-lymphocyte (CTL)-mediated lysis, H
uman peripheral blood CD4(+) lymphocytes showed strong proliferation in res
ponse to NPICs, likely because of occasional swine leukocyte antigen (SLA)
class II+ cells in the NPIC preparations. In contrast, human peripheral blo
od CD8(+) lymphocytes did not proliferate in response to NPICs, although th
ey showed clear responses to both porcine splenocytes and endothelial cells
, Both human CTL-raised-against-porcine splenocytes and endogenous NK cells
lysed porcine splenocytes,but the same cells showed little or no lytic act
ivity against NPICs, Lysis of porcine splenocyte targets was completely abr
ogated by pretreatment of the human NK or CTL populations with concana-myci
n A, suggesting a perforin-dependent effector mechanism. Pretreatment of th
e NPIC targets with proinflammatory porcine cytokines to upregulate SLA cla
ss I expression failed to enhance human CTL-mediated lysis. However, lysis
of NPICs by human CTLs could be elicited when a lectin was added to form st
able effector:target cell conjugates. It appears that NPICs do not express
sufficiently high levels of co-stimulatory and/or adhesion molecules to eit
her activate human CD8+ T-cells or to be effective targets for activated hu
man CTLs, These data suggest that NPICs may not be destroyed by NK- or CTL-
mediated lytic mechanisms after transplantation into humans.